Tendril
Device Cardiac Rhythm Management
PDI 05414734505055
General payments
$136,780
Research payments
$155,619
Through program year 2024, $136,780 in general payments and $155,619 in research payments were reported against Tendril (Cardiac Rhythm Management).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $20,858 | 641 |
| 2024 | Research | $14,805 | 10 |
| 2023 | General | $56,526 | 447 |
| 2023 | Research | $134,314 | 32 |
| 2022 | General | $59,397 | 614 |
| 2022 | Research | $6,500 | 4 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.
The top 5 of 25 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 39 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
1,702 general · 46 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.